Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability

M Whitlow1, B A Bell, S L Feng

  • 1Protein Engineering Department, Enzon, Incorporated, Piscataway, NJ 08854-3998.

Protein Engineering
|November 1, 1993
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Prognostic significance of CEBPA gene mutations in acute myeloid leukemia].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2026
Same author

[Follow-up analysis of sex hormone levels and prognosis in women after hematopoietic stem cell transplantation].

Zhonghua nei ke za zhi·2023
Same author

[Choristoma of left Eustachian tube: a case report].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2022
Same author

Measuring the Joint Spectral Mode of Photon Pairs Using Intensity Interferometry.

Physical review letters·2022
Same author

Quantum-enhanced interferometry with large heralded photon-number states.

NPJ quantum information·2021
Same author

Single-shot discrimination of coherent states beyond the standard quantum limit.

Optics letters·2021

Optimizing linker length in single-chain variable fragments (sFvs) impacts binding affinity and aggregation. Longer linkers in antifluorescein and anticarcinoma sFvs improve stability and tumor targeting, while aggregation enhances avidity for repetitive antigens.

Area of Science:

  • Biotechnology
  • Immunology
  • Protein Engineering

Background:

  • Single-chain variable fragments (sFvs) are crucial in targeted therapies.
  • Linker length significantly influences sFv stability, aggregation, and binding properties.
  • Previous studies identified proteolytic susceptibility in certain sFv linker designs.

Purpose of the Study:

  • To investigate the impact of linker length and modifications on antifluorescein and anticarcinoma sFv characteristics.
  • To evaluate the influence of linker design on binding affinity, aggregation, and proteolytic stability.
  • To assess the in vivo performance of modified sFvs in tumor models.

Main Methods:

  • Design and synthesis of novel linker sequences, including the 218 linker with a proline modification.

Related Experiment Videos

  • Characterization of sFv binding affinity, aggregation, and proteolytic stability in vitro.
  • In vivo studies in mice to evaluate blood clearance, tumor uptake, and biodistribution of radiolabeled sFvs.

    • Main Results:

    • Longer linkers in antifluorescein sFvs correlated with higher binding affinities and reduced aggregation.
    • The CC49 sFv with the 218 linker exhibited reduced aggregation and enhanced in vitro proteolytic stability compared to the CC49/212 sFv.
    • While CC49/218 sFv showed higher tumor uptake due to proteolysis resistance, aggregated CC49/212 sFv demonstrated higher affinity and tumor uptake attributed to multivalent avidity.

    Conclusions:

    • Linker engineering is a critical strategy for optimizing sFv performance in terms of stability and targeting.
    • The 218 linker design offers improved stability and tumor targeting for the CC49 sFv.
    • Aggregated sFvs can exhibit enhanced avidity, which may be beneficial for targeting repetitive antigens, despite potential stability trade-offs.